Build Your Custom Market Intelligence Report
Customize Your ReportVietnam Neurovascular Devices Market Statistics and Insights
Market Insights
- The Vietnam Neurovascular Devices Market was valued at USD 153.49 million in 2026.
- The Vietnam Neurovascular Devices Market is projected to reach USD 276.82 million by 2034.
- The market is anticipated to grow at a CAGR of 7.65% during 2026–2034.
By Device
- Cerebral Embolization and Aneurysm Coiling Devices dominate with approximately 34% share.
Competitive Landscape
- More than 10 companies are actively engaged in producing Vietnam Neurovascular Devices.
- Top 5 companies acquired around 62% of the market share.
- Stryker, Johnson & Johnson Services, Inc., Medtronic, Terumo Vietnam Co., Ltd., Penumbra, Inc., and others.
By Therapeutic Application
- Stroke leads the therapeutic segment, commanding approximately 38% market share.
Vietnam Neurovascular Devices Market Insights & Analysis
The Vietnam Neurovascular Devices Market is anticipated to register a 7.65% CAGR during 2026–2034. The market size was valued at USD 153.49 million in 2026 and is projected to reach USD 276.82 million by 2034. Vietnam's healthcare sector is undergoing a structural transformation, fueled by rising government expenditure that climbed to approximately USD 23.3 billion in 2025. Stroke remains the leading cause of death and disability in the country, accounting for 14% of all fatalities and responsible for a documented frequency increase from 1.6% in 2017 to 2.8% in 2021, generating persistent clinical demand for neurovascular intervention solutions.
Vietnam's Ministry of Health has prioritized upgrading tertiary neurology infrastructure across 47 central-level public hospitals, directly expanding adoption of advanced devices. Foreign direct investment in Vietnam's medical device sector has accelerated, with global players such as Terumo Vietnam and Stryker maintaining dedicated local operations. In February 2025, Medtronic formalized a partnership with Brainomix to integrate AI-driven imaging capabilities into stroke care pathways, a move with direct commercial implications for the Vietnamese market as local hospital networks modernize their neurointerventional suites.
Vietnam Neurovascular Devices Market Dynamics
Key Market Driver Rising Stroke Burden Fuels Device Adoption
Vietnam faces an acute and escalating stroke epidemiological burden that directly underpins demand for neurovascular devices across the forecast period. The national stroke frequency rose from 1.6% in 2017 to 2.8% in 2021, a pattern driven by rapid urbanization, rising hypertension prevalence, and an aging demographic structure. The World Health Organization projects that by 2030, one in six individuals globally will exceed 60 years of age, amplifying vulnerability to cerebrovascular events. Vietnam's healthcare expenditure is projected to reach USD 33.8 billion by 2030, enabling hospital networks to procure high-value thrombectomy systems, coiling platforms, and angioplasty devices at a sustained pace. This combination of epidemiological pressure and capital availability positions the neurovascular devices segment as one of the most consistently expanding verticals within Vietnam's medical device landscape.
Major Industry Challenge Shortage of Interventional Neurology Specialists
A critical bottleneck constraining Vietnam's neurovascular devices market is the severe shortage of trained interventional neuroradiologists and neurosurgeons capable of performing complex endovascular procedures. Globally, an estimated deficit of 23,300 neurosurgeons exists, and the shortfall is disproportionately concentrated in lower-to-middle income economies such as Vietnam, where the density of specialists falls substantially below the recommended benchmark of 0.5 to 1.0 neurosurgeons per 100,000 population. This human capital gap limits the procedural volumes necessary to justify broad procurement of sophisticated devices such as flow diverters and stent retriever systems. Government-sponsored training programs remain insufficient in scale, and overseas skill-building initiatives, while expanding, have not yet produced the specialist pipeline required to unlock the full device adoption potential across provincial hospital tiers.
Emerging Trend Shaping Outlook Minimally Invasive Endovascular Techniques Gain Traction
Across Vietnam's neurovascular devices market, a decisive shift toward minimally invasive endovascular approaches is reshaping clinical practice and procurement priorities. Neurothrombectomy devices and trans-radial access platforms are experiencing accelerated adoption as hospitals seek to reduce procedural complications, shorten patient recovery timelines, and optimize intensive care utilization. In February 2025, Penumbra launched the Access25 delivery microcatheter, a single-lumen device compatible with its 0.020-inch coil platform, illustrating the industry-wide drive toward precision-engineered, minimally invasive tools. As Vietnamese hospitals accredited for stroke intervention expand from urban centers to tier-two cities, the demand for compact, catheter-based neurovascular systems is expected to intensify substantially through 2034, rewarding suppliers with comprehensive minimally invasive portfolios.
Need Specific Data, Let’s Customize the Report for You
Request CustomizationVietnam Neurovascular Devices Market Segment-wise Analysis
Vietnam's neurovascular devices market is segmented by device type and therapeutic application, each revealing distinct adoption dynamics rooted in clinical need, infrastructure maturity, and product availability across the country's hospital network.
By Device
- Cerebral Embolization and Aneurysm Coiling Devices
- Cerebral Angioplasty and Stenting Systems
- Neurothrombectomy Devices
- Support Devices
- Trans Radial Access Devices
Cerebral Embolization and Aneurysm Coiling Devices lead the device segment, accounting for approximately 34% of market revenue. The elevated prevalence of cerebral aneurysms and the growing clinician preference for endovascular coiling over open surgical clipping has driven consistent investment in this category by leading hospitals in Ho Chi Minh City and Hanoi. Cerebral Angioplasty and Stenting Systems represent the second most significant segment at approximately 23%, benefiting from the high incidence of intracranial atherosclerotic disease in the Vietnamese population. Neurothrombectomy Devices are the fastest-growing sub-segment, propelled by the nationwide expansion of stroke intervention protocols. Trans Radial Access Devices are gaining momentum as proceduralists adopt radial approaches for their lower complication profiles, while Support Devices maintain steady demand as ancillary components for complex endovascular workflows.
|
Device Sub-Segment |
Estimated Market Share (%) |
|---|---|
|
Cerebral Embolization & Aneurysm Coiling Devices |
34% |
|
Cerebral Angioplasty & Stenting Systems |
23% |
|
Neurothrombectomy Devices |
21% |
|
Support Devices |
14% |
|
Trans Radial Access Devices |
8% |
By Therapeutic Application
- Stroke
- Cerebral Artery
- Cerebral Aneurysm
- Others
The stroke therapeutic application segment commands the largest revenue share at approximately 38%, driven by Vietnam's documented rise in stroke incidence and government-mandated expansion of dedicated stroke centers. Cerebral Aneurysm represents the second-largest application at approximately 29%, supported by growing clinical evidence favoring endovascular coiling and flow diversion techniques that minimize surgical morbidity. Cerebral Artery disorders, including intracranial stenosis and atherosclerotic disease, account for approximately 22% of the therapeutic application segment, reflecting the widespread comorbidity of hypertension and vascular disease in the Vietnamese adult population. The Others category, encompassing arteriovenous malformations and fistulas, contributes the remaining 11%, with growth anticipated as diagnostic imaging capabilities improve in secondary hospitals.
|
Therapeutic Application |
Estimated Market Share (%) |
|---|---|
|
Stroke |
38% |
|
Cerebral Aneurysm |
29% |
|
Cerebral Artery |
22% |
|
Others |
11% |
Regional Projection of Vietnam Neurovascular Devices Market
Vietnam's neurovascular devices market is assessed across the following regional zones:
- Southern Vietnam
- Northern Vietnam
- Central Vietnam
Southern Vietnam, anchored by Ho Chi Minh City, leads the regional landscape with approximately 48% of total market revenue. The region hosts the highest concentration of tertiary-care hospitals, private medical facilities, and foreign-affiliated healthcare institutions, enabling advanced neurovascular procedures at scale. Northern Vietnam, centered on Hanoi and home to several national-level referral hospitals, accounts for approximately 35% of the market, supported by strong public healthcare investment and a growing population of aging patients. Central Vietnam holds approximately 17% market share, representing a developing but increasingly active zone as government infrastructure programs extend neurovascular care capabilities to provincial centers.
Vietnam Neurovascular Devices Market: Recent Development (2025)
- In February 2025, Penumbra, Inc. launched the Access25 delivery microcatheter, expanding its minimally invasive coiling portfolio; the company reported full-year 2024 revenues exceeding USD 1.1 billion, reflecting a year-over-year growth margin of approximately 9.4%, with Asia-Pacific representing a key incremental growth region.
- Medtronic entered a strategic partnership with Brainomix in early 2025 to deploy AI-driven imaging software for stroke care networks across Asia, including distribution channels active in Vietnam's tertiary hospital ecosystem; Medtronic's neurovascular division posted operating margins of approximately 17.2% for fiscal year 2025.
- Terumo Vietnam Co., Ltd. strengthened its local distribution network in 2025, expanding partnerships with provincial hospitals in the Mekong Delta region to broaden access to its neurovascular catheter and coiling product lines.
- Stryker continued investment in its Vietnamese commercial operations throughout 2025, with targeted training programs for neurosurgeons at national stroke centers to support adoption of its Trevo thrombectomy and Target coiling platforms.
Vietnam Neurovascular Devices Market Future Outlook (2034)
The Vietnam Neurovascular Devices Market is positioned for sustained expansion at a 7.65% CAGR through 2034, reaching USD 276.82 million. Growth opportunities will be concentrated in neurothrombectomy and trans-radial access categories as minimally invasive endovascular protocols become standard across all major hospital tiers. Government investment in neurology center accreditation and the continued rollout of stroke care pathways will expand the addressable patient population significantly. Technological advancement in AI-assisted imaging navigation, robot-guided catheter systems, and next-generation flow diversion platforms will raise the clinical standard for neurovascular intervention. Long-term expansion into tier-two and tier-three Vietnamese cities will unlock a previously underserved patient base, and public-private partnerships will accelerate device procurement cycles well into the next decade.
Vietnam Neurovascular Devices Market Report Coverage
|
Report Features |
Details |
|---|---|
|
Market Value (2026) |
USD 153.49 Million |
|
Market Value (2034) |
USD 276.82 Million |
|
CAGR (2026–2034) |
7.65% |
|
Forecast Period |
2026–2034 |
|
Base Year |
2026 |
|
Historical Data |
2021–2025 |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Drivers, Trends, Challenges |
|
Segments Covered |
By Device, By Therapeutic Application, and By End User |
|
Key Players |
Stryker, Johnson & Johnson Services Inc., Medtronic, Terumo Vietnam Co. Ltd., Penumbra Inc., Others |
|
Customization |
Available |
|
Delivery Formats |
PPT, PDF & Excel |
Why Choose This Report?
- Provides a comprehensive overview of the overall market analysis, encompassing key trends, consumer behavior analysis, and risk assessment to support strategic decision-making.
- Provides accurate, up-to-date insights into market size, segmentation, and emerging opportunities, helping to minimize risk & capitalizing on growth.
- Gives deep understanding of target audience preferences, investment habits, and communication channels for enhanced product development & marketing effectiveness.
- Delivers competitive analysis & benchmarking, uncovering the strengths & weaknesses of market competitors to guide strategies.
- Consolidate comprehensive market intelligence, reducing reasoning & streamlining research efforts.
- Facilitates customized market segmentation & risk mitigation strategies, fine-tuned to the business objectives.
- Aids in identifying both market challenges & untapped opportunities within the industry to drive long-term business growth.
- Provides valuable information based on actual customer data & search trends.
Table of Contents
- Introduction
- Objective of the study
- Product Definition
- Market Segmentation
- Study Variables
- Research Methodology
- Secondary Data Points
- Companies Interviewed
- Primary Data Points
- Breakdown of Primary Interviews
- Secondary Data Points
- Executive Summary
- Market Dynamics
- Drivers
- Challenges
- Opportunity Assessment
- Recent Trends and Developments
- Policy and Regulatory Landscape
- Vietnam Neurovascular Devices Market Overview and Forecast Analysis (2021-2034)
- Market Size, By Value, By growth rate (CAGR/USD Millions)
- Demand - Supply Trends
- Market Share, By Device
- Cerebral Embolization and Aneurysm Coiling Devices
- Cerebral Angioplasty and Stenting Systems
- Neurothrombectomy Devices
- Support Devices
- Trans Radial Access Devices
- Market Share, By Therapeutic Application
- Stroke
- Cerebral Artery
- Cerebral Aneurysm
- Others
- Market Share, By End User
- Hospitals
- Specialty Clinics
- Others
- Market Share, By Region
- Southern Vietnam
- Northern Vietnam
- Central Vietnam
- Market Share, By Competitors
- Competition Characteristics
- Revenue Shares
- Vietnam Cerebral Embolization and Aneurysm Coiling Devices Neurovascular Devices Market Overview, 2021-2034F
- By Value (USD Million)
- By Therapeutic Application- Market Size & Forecast 2021-2034, USD Million
- By End User- Market Size & Forecast 2021-2034, USD Million
- Vietnam Cerebral Angioplasty and Stenting Systems Neurovascular Devices Market Overview, 2021-2034F
- By Value (USD Million)
- By Therapeutic Application- Market Size & Forecast 2021-2034, USD Million
- By End User- Market Size & Forecast 2021-2034, USD Million
- Vietnam Neurothrombectomy Devices Neurovascular Devices Market Overview, 2021-2034F
- By Value (USD Million)
- By Therapeutic Application- Market Size & Forecast 2021-2034, USD Million
- By End User- Market Size & Forecast 2021-2034, USD Million
- Vietnam Support Devices Neurovascular Devices Market Overview, 2021-2034F
- By Value (USD Million)
- By Therapeutic Application- Market Size & Forecast 2021-2034, USD Million
- By End User- Market Size & Forecast 2021-2034, USD Million
- Vietnam Trans Radial Access Devices Neurovascular Devices Market Overview, 2021-2034F
- By Value (USD Million)
- By Therapeutic Application- Market Size & Forecast 2021-2034, USD Million
- By End User- Market Size & Forecast 2021-2034, USD Million
- Competitive Outlook (Company Profile - Partial List)
- Stryker
- Company Overview
- Business Segments
- Strategic Alliances/Partnerships
- Recent Developments
- Johnson & Johnson Services, Inc.
- Company Overview
- Business Segments
- Strategic Alliances/Partnerships
- Recent Developments
- Medtronic
- Company Overview
- Business Segments
- Strategic Alliances/Partnerships
- Recent Developments
- Terumo Vietnam Co., Ltd.
- Company Overview
- Business Segments
- Strategic Alliances/Partnerships
- Recent Developments
- Penumbra, Inc.
- Company Overview
- Business Segments
- Strategic Alliances/Partnerships
- Recent Developments
- Others
- Stryker
- Contact Us & Disclaimer
Top Key Players & Market Share Outlook
- Stryker
- Johnson & Johnson Services, Inc.
- Medtronic
- Terumo Vietnam Co., Ltd.
- Penumbra, Inc.
- Others
Frequently Asked Questions





